GenTech Posts Strong Quarterly Report Featuring Breakout Growth in Revenues & Inventory on Hand coupled with large Decreases in Liabilities
September 15, 2021 09:15 ET
|
GenTech Holdings Inc.
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- GenTech Holdings, Inc. (OTC Pink: GTEH) (“GenTech” or the “Company”), an emerging leader in the Functional Foods and Nutritional Supplement marketplaces,...
Immatics veröffentlicht Ergebnisse des zweiten Quartals 2021 sowie ein Update zur Geschäftsentwicklung
August 10, 2021 07:00 ET
|
Immatics N.V.
Patientenrekrutierung für die ACTengine®-Studien verläuft weiterhin nach Plan; bis Ende Juli wurden insgesamt 27 Patienten mit unterschiedlichen Krebserkrankungen mit den Produktkandidaten IMA201,...
Immatics Announces Second Quarter 2021 Financial Results and Provides Business Update
August 10, 2021 07:00 ET
|
https://immatics.com/
ACTengine® patient recruitment remains on track; as of end of July, a total of 27 patients have been treated with IMA201, IMA202 or IMA203 across different cancer indicationsTCR Bispecifics pipeline...
Grapefruit USA Reports Cannabis Bumper Crop, Lower Demand due to Pandemic and Economic Uncertainty Contributed to Small Year-over-Year Revenue Decrease
May 25, 2021 15:24 ET
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc., (“GPFT,” “Grapefruit” or the “Company”) (OTCQB: GPFT) a California based...
Immatics veröffentlicht Ergebnisse des ersten Quartals 2021 sowie ein Update zur Geschäftsentwicklung
May 18, 2021 07:00 ET
|
Immatics N.V.
Daten-Update zu den laufenden klinischen Studien der ACTengine® IMA200 Serie zeigte erste Anti-Tumorwirkung in stark vorbehandelten Patienten mit soliden Tumoren in der frühen Phase der...
Immatics Announces First Quarter 2021 Financial Results and Business Update
May 18, 2021 07:00 ET
|
https://immatics.com/
Data update for ongoing ACTengine® IMA200 clinical trial series demonstrated first anti-tumor activity in heavily pre-treated solid cancer patients during early phases of dose escalationNext...
Immatics veröffentlicht Ergebnisse des Geschäftsjahres 2020 sowie ein Update zur Geschäftsentwicklung
March 30, 2021 07:00 ET
|
Immatics N.V.
Erste Anti-Tumorwirkung in den ACTengine® Phase 1a-Studien gezeigtPatientenrekrutierung für die klinischen ACTengine® Studien in Deutschland und USA weiter ausgebautZum 31. Dezember 2020 verfügte...
Immatics Announces Full Year 2020 Financial Results and Corporate Update
March 30, 2021 07:00 ET
|
https://immatics.com/
Phase 1a data update from clinical ACTengine® programs demonstrated first anti-tumor activity at early phases of dose escalation in heavily pre-treated solid cancer patients Enrollment across...
PCS Edventures! Reports Unaudited Results for the Third Quarter of Fiscal Year 2021
February 15, 2021 11:49 ET
|
PCS Edventures!, Inc.
BOISE, Idaho, Feb. 15, 2021 (GLOBE NEWSWIRE) -- PCS Edventures!, Inc., (PCSV) a leading provider of K-12 Science, Technology, Engineering and Mathematics (STEM) education programs and drone...
Oceana: Amazon (AMZN) reports 38% increase in sales for 2020, but does not address corresponding increase in the company’s plastic use as Bezos plans to step down
February 03, 2021 17:30 ET
|
Oceana, Inc.
Oceana calls on company and CEO Jeff Bezos to lead e-commerce industry in showing how to reduce plastics in wake of record-breaking earnings report WASHINGTON, Feb. 03, 2021 (GLOBE NEWSWIRE) --...